Teton Brings Home-Based Heart Monitoring Closer with MyECGAI Pro Launch

In a notable step for locally developed health technology, Teton Private Limited has released MyECGAI Pro, an artificial intelligence-powered portable 12-lead electrocardiogram device designed for use at home or while traveling. The product was unveiled on 11 October 2026 during a ceremony at the Sheraton Dhaka Hotel in Banani. The event drew academics, physicians, and business representatives, reflecting growing interest in practical medical tools created inside the country.

MyECGAI Pro allows a user to record the heart's electrical activity in approximately 30 seconds. After the short session, the device produces a digital PDF report that can be saved or shared immediately with a registered medical practitioner. The company says the AI component reviews the recording for a range of cardiac conditions, offering an initial analysis that may help people decide whether they need further medical attention. This approach aims to reduce the frequency of routine visits to diagnostic centers while still supporting quicker remote consultation when someone experiences discomfort.

The technology was developed in collaboration with the Bangladesh University of Engineering and Technology (BUET). It has also been validated by the National Heart Foundation of Bangladesh. At the launch, Professor Dr. Kamrul Hasan, Dean of the Faculty of Electrical and Electronic Engineering at BUET, attended as chief guest. Professor (Dr.) Khondker Abdul Awal Rizvi, President of the National Heart Foundation, was present as special guest. Their participation highlighted the links between academic research, clinical validation, and commercial product development.

The device is compact and easy to carry, so users can perform a recording almost anywhere rather than relying solely on fixed hospital equipment. Teton has described it as a way to make basic cardiac screening more accessible. In a country where heart-related conditions are a significant public-health concern and where travel to specialized centers can be time-consuming, a tool that delivers a shareable report in half a minute has clear practical appeal. The PDF format is intended to fit existing digital communication habits, allowing patients or family members to forward results to a doctor without physical paperwork.

Earlier in the month, the underlying MyECGAI solution received the Champion Award in the Organisation (Consumer) category at the Bangladesh ICT and Innovation Awards 2026. The awards, organized by the Bangladesh ICT and Innovation Network, recognized a selection of projects from hundreds of submissions. The recognition placed Teton's cardiac-screening work among a small group of institutional innovations that advanced to the highest tier. Company representatives have linked the award and the subsequent product launch as part of a broader effort to move from concept to usable technology.

Dr. Athar Uddin, Chairman of Azmat Group, spoke at the event on behalf of the investors, underscoring the commercial interest in health-focused electronics. Teton has indicated that it continues to work in health technology alongside its consumer electronics activities. The launch included a demonstration of the device and an explanation of how the recording and reporting process works, giving attendees a direct look at the hardware and the AI-assisted output.

For users, the main promise is convenience paired with speed. A 30-second recording followed by an immediate digital report lowers the barrier for occasional checks. It does not replace professional medical diagnosis, but it can serve as an early information point that a physician can review. In settings where diagnostic centers are crowded or distant, such a device may help people monitor symptoms between formal visits or share data more easily during a remote consultation.

The introduction of MyECGAI Pro also fits into a wider pattern of local innovation in Bangladesh's technology sector. Recent months have seen recognition for various homegrown projects, including tools in agriculture, climate adaptation, and digital services.

Health technology remains an area with both need and opportunity, and products that combine hardware with AI analysis are drawing attention from universities, regulators, and investors. Whether MyECGAI Pro gains wide adoption will depend on pricing, distribution, user experience, and clinical acceptance over time. For now, the launch marks a concrete example of a Bangladeshi company moving an AI-assisted medical device from development and award recognition into the market.